For the trading week ended February 25, 2022, there was a decrease of 4.1% in my proprietary Canadian Cannabis Company Index (MCCCI) compared to the prior week when there was a decrease of 16.0%. The index consists of 22 stocks, many of which are among the most widely held holdings of the 3 ETFs (MJ, CNBS, and THCX) that I consider to be a reliable barometer of the Canadian cannabis sector.

Image by Herbal Hemp from Pixabay

The MCCCI's differentiated business model is both weighted and market capitalization based because I believe that this approach best represents the current landscape of the Canadian cannabis sector. Now let us look at this week’s good, bad, and ugly stocks.

The Good

There was 1 stock that increased by more than 10% which is my metric for inclusion in this category: NEPT +18.8 %.

The Bad

There were 2 stocks that decreased by more than 10% (but less than 20%) which is my metric for inclusion in this category: WDDMF –14.0% and VVCIF –13.8%.

The Ugly

There were no stocks that decreased by 20% or more, which is my metric for inclusion in this category.

Valuation Metric Review

There was a decrease of 5.1% in the “Big Four” compared to the prior week when there was a decrease of 12.7%. All of the “Big Four” decreased except CRON, which increased marginally.

Recap

Only 4 of the 22 stocks in the portfolio increased. There was an increase of 1.7% in the relative strength index compared to the prior week when there was a decrease of 24.0%. Let us see how this volatile sector has performed at the same time next week shall we?